These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 10652801)

  • 1. [Bone mass evolution in patients with precocious and advanced puberty treated with LHRH analogs].
    Ruiz-Echarri M; Ferrández Longás A; Mayayo Dehesa E
    An Esp Pediatr; 1999 Nov; 51(5):499-504. PubMed ID: 10652801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
    Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK; Fan X; Tang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
    Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and body composition in Thai Precocious Puberty girls treated with GnRH agonist.
    Wacharasindhu S; Petwijit T; Aroonparkmongkol S; Srivuthana S; Kingpetch K
    J Med Assoc Thai; 2006 Aug; 89(8):1194-8. PubMed ID: 17048429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A; Sharma J; Kabra M; Gupta AK; Menon PS
    Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.
    Bertelloni S; Mul D
    Asian J Androl; 2008 Jul; 10(4):525-34. PubMed ID: 18478155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus on the diagnosis and treatment of central early puberty].
    García H; Youlton R; Burrows R; Catanni A;
    Rev Med Chil; 2003 Jan; 131(1):95-110. PubMed ID: 12643227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of precocious puberty in internationally adopted children in Denmark.
    Teilmann G; Pedersen CB; Skakkebaek NE; Jensen TK
    Pediatrics; 2006 Aug; 118(2):e391-9. PubMed ID: 16882780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists.
    Wacharasindhu S; Srivuthana S; Aroonparkmongkol S; Supornsilchai V; Hiranrat P; Yodvisitsak V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S170-3. PubMed ID: 12929985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
    Mul D; Oostdijk W; Waelkens JJ; Drop SL
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment.
    Su PH; Wang SL; Lin CY; Chen JY; Changlai CP; Jian SH; Chen SJ
    Acta Paediatr Taiwan; 2005; 46(5):278-83. PubMed ID: 16640001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precocious puberty.
    Papathanasiou A; Hadjiathanasiou C
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():182-7. PubMed ID: 16641856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LHRH and analogs: contraceptive and therapeutic considerations.
    Corbin A; Bex FJ; Jones RC
    Int J Fertil; 1985; 30(1):57-65. PubMed ID: 2862121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
    Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.